
“Amaron's lead-acid moat frays as FIIs exit.”
No clear market view today
The signals we track (volume, delivery, price trend, deals, breadth and flows) aren't aligned for ARE&Mtoday. That isn't bearish, just inconclusive.
MACD is below signal line with negative momentum
India-specific risk checks.
Four fundamentals lenses on the company itself: valuation, growth, returns & margins, and financial health, judged against the stock's sector. A separate read from the Market Setup above.
Trading at attractive valuations
₹1,000 invested here buys about ₹58 of annual profit. A cheaper stock would buy more.
Growth is soft or negative
Moderate returns
Strong balance sheet
Data as of 19 Jun 2026, 9:30 pm